View in EDS

Improving CDK4/6 inhibitors adherence in breast cancer using the CONnected CUstomized Treatment Platform (CONCURxP) mobile health intervention: Study protocol for ECOG-ACRIN EAQ221CD.

Saved in:
Bibliographic Details
Title: Improving CDK4/6 inhibitors adherence in breast cancer using the CONnected CUstomized Treatment Platform (CONCURxP) mobile health intervention: Study protocol for ECOG-ACRIN EAQ221CD.
Authors: Sadigh G; Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, CA, United States of America. Electronic address: gsadigh@uci.edu., Duan F; Brown University - ECOG-ACRIN Biostatistics Center, Providence, RI, United States of America., Gareen IF; Brown University - ECOG-ACRIN Biostatistics Center, Providence, RI, United States of America; Brown University School of Public Health Department of Epidemiology, Providence, RI, United States of America., Hancock J; Cancer Research for the Ozarks NCORP, Springfield, MO, United States of America., Sicks JD; Brown University - ECOG-ACRIN Biostatistics Center, Providence, RI, United States of America., Thangarajah M; Brown University - ECOG-ACRIN Biostatistics Center, Providence, RI, United States of America., Meisel JL; Winship Cancer Institute, Emory University, Atlanta, GA, United States of America., Torres MA; Winship Cancer Institute, Emory University, Atlanta, GA, United States of America., Ramsey SD; Hutchinson Institute for Cancer Outcomes Research, Seattle, WA, United States of America., Wolff AC; Sidney Kimmel Cancer Center, John Hopkins University, MD, United States of America., Wagner LI; University of North Carolina at Chapel Hill, NC, United States of America., Carlos RC; Columbia University, New York, NY, United States of America., Graetz I; Winship Cancer Institute, Emory University, Atlanta, GA, United States of America.
Source: Contemporary clinical trials [Contemp Clin Trials] 2026 Jan; Vol. 160, pp. 108145. Date of Electronic Publication: 2025 Nov 18.
Publication Type: Journal Article; Clinical Trial Protocol
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101242342 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-2030 (Electronic) Linking ISSN: 15517144 NLM ISO Abbreviation: Contemp Clin Trials Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41265834
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Improving CDK4/6 inhibitors adherence in breast cancer using the CONnected CUstomized Treatment Platform (CONCURxP) mobile health intervention: Study protocol for ECOG-ACRIN EAQ221CD.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sadigh+G%22">Sadigh G</searchLink>; Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, CA, United States of America. Electronic address: gsadigh@uci.edu.<br /><searchLink fieldCode="AU" term="%22Duan+F%22">Duan F</searchLink>; Brown University - ECOG-ACRIN Biostatistics Center, Providence, RI, United States of America.<br /><searchLink fieldCode="AU" term="%22Gareen+IF%22">Gareen IF</searchLink>; Brown University - ECOG-ACRIN Biostatistics Center, Providence, RI, United States of America; Brown University School of Public Health Department of Epidemiology, Providence, RI, United States of America.<br /><searchLink fieldCode="AU" term="%22Hancock+J%22">Hancock J</searchLink>; Cancer Research for the Ozarks NCORP, Springfield, MO, United States of America.<br /><searchLink fieldCode="AU" term="%22Sicks+JD%22">Sicks JD</searchLink>; Brown University - ECOG-ACRIN Biostatistics Center, Providence, RI, United States of America.<br /><searchLink fieldCode="AU" term="%22Thangarajah+M%22">Thangarajah M</searchLink>; Brown University - ECOG-ACRIN Biostatistics Center, Providence, RI, United States of America.<br /><searchLink fieldCode="AU" term="%22Meisel+JL%22">Meisel JL</searchLink>; Winship Cancer Institute, Emory University, Atlanta, GA, United States of America.<br /><searchLink fieldCode="AU" term="%22Torres+MA%22">Torres MA</searchLink>; Winship Cancer Institute, Emory University, Atlanta, GA, United States of America.<br /><searchLink fieldCode="AU" term="%22Ramsey+SD%22">Ramsey SD</searchLink>; Hutchinson Institute for Cancer Outcomes Research, Seattle, WA, United States of America.<br /><searchLink fieldCode="AU" term="%22Wolff+AC%22">Wolff AC</searchLink>; Sidney Kimmel Cancer Center, John Hopkins University, MD, United States of America.<br /><searchLink fieldCode="AU" term="%22Wagner+LI%22">Wagner LI</searchLink>; University of North Carolina at Chapel Hill, NC, United States of America.<br /><searchLink fieldCode="AU" term="%22Carlos+RC%22">Carlos RC</searchLink>; Columbia University, New York, NY, United States of America.<br /><searchLink fieldCode="AU" term="%22Graetz+I%22">Graetz I</searchLink>; Winship Cancer Institute, Emory University, Atlanta, GA, United States of America.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101242342%22">Contemporary clinical trials</searchLink> [Contemp Clin Trials] 2026 Jan; Vol. 160, pp. 108145. <i>Date of Electronic Publication: </i>2025 Nov 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial Protocol
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101242342 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1559-2030 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215517144%22">15517144 </searchLink><i>NLM ISO Abbreviation: </i>Contemp Clin Trials <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41265834
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.cct.2025.108145
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 108145
    Titles:
      – TitleFull: Improving CDK4/6 inhibitors adherence in breast cancer using the CONnected CUstomized Treatment Platform (CONCURxP) mobile health intervention: Study protocol for ECOG-ACRIN EAQ221CD.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sadigh G
      – PersonEntity:
          Name:
            NameFull: Duan F
      – PersonEntity:
          Name:
            NameFull: Gareen IF
      – PersonEntity:
          Name:
            NameFull: Hancock J
      – PersonEntity:
          Name:
            NameFull: Sicks JD
      – PersonEntity:
          Name:
            NameFull: Thangarajah M
      – PersonEntity:
          Name:
            NameFull: Meisel JL
      – PersonEntity:
          Name:
            NameFull: Torres MA
      – PersonEntity:
          Name:
            NameFull: Ramsey SD
      – PersonEntity:
          Name:
            NameFull: Wolff AC
      – PersonEntity:
          Name:
            NameFull: Wagner LI
      – PersonEntity:
          Name:
            NameFull: Carlos RC
      – PersonEntity:
          Name:
            NameFull: Graetz I
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2026 Jan
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1559-2030
          Numbering:
            – Type: volume
              Value: 160
          Titles:
            – TitleFull: Contemporary clinical trials
              Type: main
ResultId 1